Peptide stacks · Growth hormone

CJC-1295 with DAC and ipamorelin stack: what’s in it and the evidence

Checked against our library and study pagesPublished by PepVault

The CJC-1295 with DAC and ipamorelin stack is two compounds run side by side, each from its own vial or form: CJC-1295 with DAC and ipamorelin. The library records CJC-1295 with DAC at 1–2 mg and ipamorelin at 200–300 mcg per dose as reference ranges.

This page describes what the crowd runs and what a vial holds. It recommends no stack and names no seller.

What’s in the CJC-1295 with DAC and ipamorelin stack

The two parts of the CJC-1295 with DAC and ipamorelin stack
PartReference rangeFiled underEvidence (library)
CJC-1295 with DAC1–2 mgSustained GH, Weekly dosing, IGF-1 elevationModerate
Ipamorelin200–300 mcgGH release, Sleep quality, RecoveryModerate

The library’s reference range per dose, part by part

  • CJC-1295 with DAC1–2 mg

  • Ipamorelin200–300 mcg

Each bar runs from the low to the high end of what the library records for each part of the CJC-1295 with DAC and ipamorelin stack, on one scale.

CJC-1295 with DAC

CJC-1295 with DAC is one of the two parts of the CJC-1295 with DAC and ipamorelin stack. A long-acting growth hormone releasing hormone analogue: the DAC modification extends its half-life to about a week, so one weekly injection keeps GH and IGF-1 raised, lifting baseline GH while natural pulses continue.

Ipamorelin

Ipamorelin is one of the two parts of the CJC-1295 with DAC and ipamorelin stack. Considered the 'cleanest' growth hormone stimulator: in animal studies it triggers the pituitary to release GH without raising cortisol, a side effect common with other GH peptides.

A smiling man in a navy t-shirt at his garage gym, a towel over his shoulder, holding his phone

PepVault for iPhone

Track your stack in PepVault

Log every compound in a stack, each on its own schedule, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Has the CJC-1295 with DAC and ipamorelin stack been studied as a combination?

None of our 436 study pages tested CJC-1295 with DAC and ipamorelin together, so the CJC-1295 with DAC and ipamorelin stack rests on studies of its parts and on community reports.

The studies of the parts, one by one: 5 study pages on CJC-1295 with DAC (3 in people) and 10 study pages on ipamorelin (1 in people).

What people commonly report on the CJC-1295 with DAC and ipamorelin stack

The library holds no report of what people notice on the CJC-1295 with DAC and ipamorelin stack as a pair. What it records for each part on its own:

  • CJC-1295 with DAC: water retention and puffiness, sometimes tingling hands, over the first weeks, and tiredness in the days after the shot.
  • Ipamorelin: deeper sleep and vivid dreams first, then better recovery, skin quality and gradual body-composition changes, with milder hunger than GHRP-6.

These are reports from people who run it, collected in the library, not results from a trial and not a promise of what any one person will notice.

Why these are combined

The library’s note on the pair (clinical data)

CJC-1295 WITH DAC stays elevated for days, so the sharp fasted-timing rules of the no-DAC version relax — the GH baseline is continuous rather than pulsed. Ipamorelin still adds the acute pulse on top.

How the parts of the CJC-1295 with DAC and ipamorelin stack are mixed and taken

The CJC-1295 with DAC and ipamorelin stack isn’t one pre-mixed vial in the library: each part has its own route and schedule, as its entry records them.

How each part of the CJC-1295 with DAC and ipamorelin stack is taken, from its library entry
PartRouteHow oftenOur vial pages
CJC-1295 with DACSubQ injectionWeekly10 mg vial
IpamorelinSubQ injection, IM injection2–3x daily, best fasted or before bed5 mg vial

Our vial pages work out the mix for each part’s own vial, size by size:

Compared with running the parts apart

The library’s notes on the CJC-1295 with DAC and ipamorelin stack don’t compare it with running either part on its own.

Safety notes

The library holds no combination safety note on the CJC-1295 with DAC and ipamorelin stack, so each part’s own notes apply, on its compound page.

These are reference notes from published research and reported use, not advice for a person: discuss your own situation with your clinician.

Questions people ask

What is in the CJC-1295 with DAC and ipamorelin stack?

The CJC-1295 with DAC and ipamorelin stack is two compounds run side by side, each from its own vial or form: CJC-1295 with DAC and ipamorelin. The library records CJC-1295 with DAC at 1–2 mg and ipamorelin at 200–300 mcg per dose as reference ranges.

Has the CJC-1295 with DAC and ipamorelin stack been studied together?

Not as a combination in any of our study pages: the CJC-1295 with DAC and ipamorelin stack rests on studies of its parts and on community reports.

Do the parts of the CJC-1295 with DAC and ipamorelin stack come in one vial?

No: in the library each part of the CJC-1295 with DAC and ipamorelin stack is its own compound with its own route and schedule (CJC-1295 with DAC by SubQ injection and ipamorelin by SubQ injection).

What does each part of the CJC-1295 with DAC and ipamorelin stack do?

CJC-1295 with DAC: A long-acting growth hormone releasing hormone analogue: the DAC modification extends its half-life to about a week, so one weekly injection keeps GH and IGF-1 raised, lifting baseline GH while natural pulses continue. Ipamorelin: Considered the 'cleanest' growth hormone stimulator: in animal studies it triggers the pituitary to release GH without raising cortisol, a side effect common with other GH peptides.

More on these compounds

Track it in the app

PepVault for iPhone

Track your stack in PepVault

Log every compound in a stack, each on its own schedule, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo